Skip to the main content

Conference paper

AN AUDIT TO COMPARE THE EFFICACY OF TREATMENT (AS INDICATED BY DISCHARGE RATES AND REDUCTION IN SUICIDALITY) AMONG PATIENTS WITH REFRACTORY DEPRESSION IN A BEDFORDSHIRE COMMUNITY MENTAL HEALTH TEAM RECEIVING AUGMENTATION THERAPY WITH EITHER MIRTAZEPINE OR ATYPICAL ANTIPSYCHOTICS

Sophie Butler ; Foundation Programme East Anglian Deanery, UK
Clare Holt ; Foundation Programme East Anglian Deanery, UK
Mark Agius ; South Essex Partnership University Foundation NHS Trust, UK; Department of Psychiatry, University of Cambridge, UK
Rashid Zaman ; South Essex Partnership University Foundation NHS Trust, UK; Department of Psychiatry, University of Cambridge, UK


Full text: english pdf 233 Kb

page 171-174

downloads: 81

cite


Abstract

In recent years, there has been particular interest in the use of augmentation. Potential augmentation regimes include the
addition of atypical antipsychotics (e.g. risperidone/olanzapine) or other antidepressants (e.g. mirtazepine). The purpose of this
audit was to compare patient outcomes between groups receiving different augmentation strategies. Overall we found that
augmentation with mirtazepine resulted in better outcomes in terms of both discharge rates and in terms of reduction in suicidality
than augmentation with atypical antipsychotics

Keywords

augmentation; mirtazepine; atypical antipsychotics; suicidality; discharge rates

Hrčak ID:

264852

URI

https://hrcak.srce.hr/264852

Publication date:

1.9.2011.

Visits: 190 *